Clinical impact of the immunome in lymphoid malignancies: The role of myeloid-derived suppressor cells

9Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as prognostic factor. Additionally, it represents a promising tool for improving therapeutic strategies. In this context, myeloid-derived suppressor cells (MDSCs) have gained a central role in tumor developing with consequent therapeutic implications. In this review, we will focus on the biological and clinical impact of the study of MDSCs in the settings of lymphoid malignancies.

Cite

CITATION STYLE

APA

Vetro, C., Romano, A., Ancora, F., Coppolino, F., Brundo, M. V., Raccuia, S. A., … Parrinello, N. L. (2015). Clinical impact of the immunome in lymphoid malignancies: The role of myeloid-derived suppressor cells. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2015.00104

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free